Insider · CIK 0001832432
Odegard Valerie
Reports to the SEC for 2 companies · BOSTON, MA
Transactions
7
Companies
2
Filings
4
CIK
0001832432
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-07 | ODTXOdyssey Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-05-02 | SPRYARS Pharmaceuticals, Inc.A Award | — |
| 2022-05-02 | SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2022-02-01 | SPRYARS Pharmaceuticals, Inc.A Award | — |
| 2022-02-01 | SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2022-02-01 | SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2020-12-03 | SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Odegard Valerie0001193125-26-217590SEC(opens sec.gov)
- 4Odegard Valerie0001209191-22-027158SEC(opens sec.gov)
- 4Odegard Valerie0001209191-22-006434SEC(opens sec.gov)
- 4Odegard Valerie0001209191-20-062054SEC(opens sec.gov)
Companies
Address
C/O ODYSSEY THERAPEUTICS, INC. 51 SLEEPER STREET, SUITE 800
BOSTON, MA, 02210